Pulmonary Fibrosis Biomarker Market Size, Share, Opportunities, And Trends By Test Type (Blood Tests, Imaging Test, Lungs Biopsy), By Indication (Idiopathic pulmonary fibrosis (IPF), Rheumatoid Arthritis Interstitial Lung Disease (RA-ILD), Drug-induced pulmonary fibrosis, COVID-19-related pulmonary fibrosis, Pneumoconiosis, Sarcoidosis, Others), By End-User (Diagnostic Laboratories, Academic and Research Institutes, Hospital Laboratories, Biopharmaceutical Companies, Others), And By Geography - Forecasts From 2024 To 2029